Details about Izabela Jelovac

Access statistics for papers by Izabela Jelovac.

Last updated 2024-03-07. Update your information in the RePEc Author Service.

Short-id: pje19

Working Papers

2023

1. The pricing of physicians' services with distant medicine and health insurance
   Working Papers, HAL
   Also in Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon (2022)

2020

2. Regulation and altruism
   Post-Print, HAL View citations (4)
   Also in Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon (2017)
   Working Papers, HAL (2017)
   AMSE Working Papers, Aix-Marseille School of Economics, France (2017)
   See also Journal Article Regulation and altruism, Journal of Public Economic Theory, Association for Public Economic Theory (2020) View citations (5) (2020)
3. Research funding and price negotiation for new drugs
   Post-Print, HAL View citations (2)
   Also in Working Papers, HAL (2019)
   Post-Print, HAL (2019)
   Post-Print, HAL (2019)
   Post-Print, HAL (2019)
   Post-Print, HAL (2019)
   Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon (2019)
   Post-Print, HAL (2019)
   See also Journal Article Research funding and price negotiation for new drugs, Health Economics, John Wiley & Sons, Ltd. (2020) View citations (2) (2020)

2019

4. Comparing approval procedures for new drugs
   Post-Print, HAL
   See also Journal Article Comparing approval procedures for new drugs, The World Economy, Wiley Blackwell (2019) View citations (2) (2019)

2018

5. Basic, applied research, and price negotiation for new drugs
   Post-Print, HAL
6. Des « Nobels » de sciences économiques au service des systèmes de santé
   Post-Print, HAL
   Also in Post-Print, HAL (2018)
7. Enjeux tarifaires de la médecine génomique
   Post-Print, HAL

2017

8. Drug approval decision times, international reference pricing and strategic launches of new drugs
   Post-Print, HAL
   Also in Post-Print, HAL (2015)
   Working Papers, HAL (2014) View citations (3)
   Post-Print, HAL (2015)
   Post-Print, HAL (2015)
   Post-Print, HAL (2014) View citations (3)
   Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon (2014) View citations (3)
   Post-Print, HAL (2015)
9. Health Services: Incentives and Access. Keynote speech
   Post-Print, HAL
10. Health services: Incentives and access
    Post-Print, HAL
11. Incentives to patients versus incentives to health care providers: The users' perspective
    Post-Print, HAL View citations (2)
    Also in Working Papers, HAL (2015)
    Post-Print, HAL (2015)
    Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon (2015)
    See also Journal Article Incentives to patients versus incentives to health care providers: The users' perspective, Health Economics, John Wiley & Sons, Ltd. (2017) View citations (2) (2017)

2016

12. Drug approval decision times, international reference pricing and access to new drugs
    Post-Print, HAL
13. Healthcare providers’ payments with personalized medicine
    Post-Print, HAL
14. Médecine personnalisée et prix des médicaments
    Post-Print, HAL
15. Personalized medicine and drug prices
    Post-Print, HAL

2015

16. Demand versus Supply Side Cost-Sharing: Patients’ preferences
    Post-Print, HAL
17. La Médecine personnalisée
    Post-Print, HAL
18. On the relationship between the negociated price of pharmaceuticals and the patients' co-payment
    Post-Print, HAL
    Also in Post-Print, HAL (2010)
    See also Journal Article On the relationship between the negotiated prices of pharmaceuticals and the patients' co-payment, Economics Bulletin, AccessEcon (2015) View citations (14) (2015)
19. Physicians’ balance billing, supplemental insurance and access to health care
    Post-Print, HAL View citations (3)
    Also in Post-Print, HAL (2012)
    Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon (2013) View citations (4)
    Working Papers, HAL (2013) View citations (4)
    Post-Print, HAL (2011)
    Post-Print, HAL (2011)
    Post-Print, HAL (2011)
    See also Journal Article Physicians’ balance billing, supplemental insurance and access to health care, International Journal of Health Economics and Management, Springer (2015) View citations (4) (2015)

2014

20. Demand versus Supply Side Cost-Sharing: The users' perspective
    Post-Print, HAL
    Also in Post-Print, HAL (2014)
21. Drug launch timing and international reference pricing
    Post-Print, HAL View citations (2)
    Also in Post-Print, HAL (2013) View citations (3)
    Post-Print, HAL (2014) View citations (2)
    Working Papers, HAL (2013) View citations (5)
    Post-Print, HAL (2013) View citations (3)
    Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon (2013) View citations (3)
    Post-Print, HAL (2014) View citations (3)
    See also Journal Article Drug Launch Timing and International Reference Pricing, Health Economics, John Wiley & Sons, Ltd. (2015) View citations (4) (2015)
22. How should donors give foreign aid ? A theoretical comparison of aid modalities
    Post-Print, HAL
23. Payment mechanism and GP self-selection: capitation versus fee for service
    Post-Print, HAL View citations (6)
    See also Journal Article Payment mechanism and GP self-selection: capitation versus fee for service, International Journal of Health Economics and Management, Springer (2014) View citations (8) (2014)
24. Primary Care, Gatekeeping and Incentives
    Post-Print, HAL View citations (6)

2013

25. Perception du lien entre mode de rémunération et comportement des médecins
    Post-Print, HAL
    Also in Post-Print, HAL (2011)

2012

26. External Reference Pricing and Sequential Launching of Drugs
    Post-Print, HAL
27. Preferences for Demand versus Supply Side Cost-Sharing
    Post-Print, HAL

2011

28. External referencing and pharmaceutical price negotiation
    Post-Print, HAL View citations (16)
    Also in Post-Print, HAL (2010) View citations (2)
    Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon (2008) View citations (1)
    See also Journal Article External referencing and pharmaceutical price negotiation, Health Economics, John Wiley & Sons, Ltd. (2011) View citations (15) (2011)
29. Treatment and referral decisions under different physician payment mechanisms
    Post-Print, HAL View citations (61)
    See also Journal Article Treatment and referral decisions under different physician payment mechanisms, Journal of Health Economics, Elsevier (2011) View citations (51) (2011)

2010

30. Physicians self selection of a payment mechanism: Capitation versus fee-for-service
    Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon View citations (2)
    Also in Post-Print, HAL (2010) View citations (1)
31. Physicians' Balance Billing, Fees Negotiations and Supplementary Insurance
    Post-Print, HAL
    Also in Post-Print, HAL (2010)
    Post-Print, HAL (2010)

2008

32. How Should Donors Give Foreign Aid? Project Aidversus Budget Support
    CREPP Working Papers, Centre de Recherche en Economie Publique et de la Population (CREPP) (Research Center on Public and Population Economics) HEC-Management School, University of Liège View citations (4)
    Also in Post-Print, HAL (2008) View citations (8)
    Working Papers, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon (2008) View citations (8)

2007

33. Do free-of-charge public health services impede cost recovery policies in Khartoum state, Sudan?
    Post-Print, HAL View citations (1)

2006

34. Household health-seeking behaviour in Khartoum, Sudan: The willingness to pay for public health services if these services are of good quality
    Post-Print, HAL
    See also Journal Article Household health-seeking behaviour in Khartoum, Sudan: The willingness to pay for public health services if these services are of good quality, Health Policy, Elsevier (2006) View citations (7) (2006)

2005

35. Pricing and Welfare Implications of Parallel Imports in the Pharmaceutical Industry
    Post-Print, HAL View citations (1)
    See also Journal Article Pricing and Welfare Implications of Parallel Imports in the Pharmaceutical Industry, International Journal of Health Economics and Management, Springer (2005) View citations (54) (2005)

2003

36. GPs’ payment contracts and their referral practice
    Post-Print, HAL View citations (6)
    See also Journal Article GPs' payment contracts and their referral practice, Journal of Health Economics, Elsevier (2003) View citations (39) (2003)
37. Pricing and Welfare of Parallel Imports in the Pharmaceutical Industry
    Research Memorandum, Maastricht University, Maastricht Economic Research Institute on Innovation and Technology (MERIT) View citations (1)

2002

38. Comparing organizational structures in health services
    Post-Print, HAL View citations (2)
    Also in UFAE and IAE Working Papers, Unitat de Fonaments de l'Anàlisi Econòmica (UAB) and Institut d'Anàlisi Econòmica (CSIC) (1998) View citations (1)
    See also Journal Article Comparing organizational structures in health services, Journal of Economic Behavior & Organization, Elsevier (2002) View citations (23) (2002)

2000

39. GPs’ Payment Contracts and their Referral Policy
    Documentos de trabajo - Analise Economica, IDEGA - Instituto Universitario de Estudios e Desenvolvemento de Galicia View citations (2)

Journal Articles

2020

1. Regulation and altruism
   Journal of Public Economic Theory, 2020, 22, (1), 49-68 View citations (5)
   See also Working Paper Regulation and altruism, Post-Print (2020) View citations (4) (2020)
2. Research funding and price negotiation for new drugs
   Health Economics, 2020, 29, (S1), 83-96 View citations (2)
   See also Working Paper Research funding and price negotiation for new drugs, Post-Print (2020) View citations (2) (2020)

2019

3. Comparing approval procedures for new drugs
   The World Economy, 2019, 42, (5), 1598-1619 View citations (2)
   See also Working Paper Comparing approval procedures for new drugs, Post-Print (2019) (2019)

2017

4. Incentives to patients versus incentives to health care providers: The users' perspective
   Health Economics, 2017, 26, (12), e319-e331 View citations (2)
   See also Working Paper Incentives to patients versus incentives to health care providers: The users' perspective, Post-Print (2017) View citations (2) (2017)

2015

5. Drug Launch Timing and International Reference Pricing
   Health Economics, 2015, 24, (8), 978-989 View citations (4)
   See also Working Paper Drug launch timing and international reference pricing, Post-Print (2014) View citations (2) (2014)
6. On the relationship between the negotiated prices of pharmaceuticals and the patients' co-payment
   Economics Bulletin, 2015, 35, (1), 481-493 View citations (14)
   See also Working Paper On the relationship between the negociated price of pharmaceuticals and the patients' co-payment, Post-Print (2015) (2015)
7. Physicians’ balance billing, supplemental insurance and access to health care
   International Journal of Health Economics and Management, 2015, 15, (2), 269-280 View citations (4)
   See also Working Paper Physicians’ balance billing, supplemental insurance and access to health care, Post-Print (2015) View citations (3) (2015)

2014

8. How Should Donors Give Foreign Aid? A Theoretical Comparison of Aid Modalities
   The European Journal of Development Research, 2014, 26, (5), 886-904
9. Payment mechanism and GP self-selection: capitation versus fee for service
   International Journal of Health Economics and Management, 2014, 14, (2), 143-160 View citations (8)
   See also Working Paper Payment mechanism and GP self-selection: capitation versus fee for service, Post-Print (2014) View citations (6) (2014)

2011

10. External referencing and pharmaceutical price negotiation
    Health Economics, 2011, 20, (6), 737-756 View citations (15)
    See also Working Paper External referencing and pharmaceutical price negotiation, Post-Print (2011) View citations (16) (2011)
11. Treatment and referral decisions under different physician payment mechanisms
    Journal of Health Economics, 2011, 30, (5), 880-893 View citations (51)
    See also Working Paper Treatment and referral decisions under different physician payment mechanisms, Post-Print (2011) View citations (61) (2011)

2006

12. Household health-seeking behaviour in Khartoum, Sudan: The willingness to pay for public health services if these services are of good quality
    Health Policy, 2006, 75, (2), 140-158 View citations (7)
    See also Working Paper Household health-seeking behaviour in Khartoum, Sudan: The willingness to pay for public health services if these services are of good quality, Post-Print (2006) (2006)

2005

13. Pricing and Welfare Implications of Parallel Imports in the Pharmaceutical Industry
    International Journal of Health Economics and Management, 2005, 5, (1), 5-21 View citations (54)
    See also Working Paper Pricing and Welfare Implications of Parallel Imports in the Pharmaceutical Industry, Post-Print (2005) View citations (1) (2005)

2003

14. GPs' payment contracts and their referral practice
    Journal of Health Economics, 2003, 22, (4), 617-635 View citations (39)
    See also Working Paper GPs’ payment contracts and their referral practice, Post-Print (2003) View citations (6) (2003)

2002

15. Comparing organizational structures in health services
    Journal of Economic Behavior & Organization, 2002, 49, (4), 501-522 View citations (23)
    See also Working Paper Comparing organizational structures in health services, Post-Print (2002) View citations (2) (2002)

2001

16. Physicians' payment contracts, treatment decisions and diagnosis accuracy
    Health Economics, 2001, 10, (1), 9-25 View citations (17)